Last $0.16 USD
Change Today +0.004 / 2.50%
Volume 62.4K
ARYC On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

arrayit corp (ARYC) Snapshot

Open
$0.19
Previous Close
$0.16
Day High
$0.19
Day Low
$0.16
52 Week High
11/14/13 - $0.95
52 Week Low
04/29/14 - $0.10
Market Cap
6.5M
Average Volume 10 Days
38.5K
EPS TTM
$-0.03
Shares Outstanding
39.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ARRAYIT CORP (ARYC)

Related News

No related news articles were found.

arrayit corp (ARYC) Related Businessweek News

No Related Businessweek News Found

arrayit corp (ARYC) Details

Arrayit Corporation, a life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide. The company is involved in the development and support of microarray tools and components; custom printing and analysis of microarrays for research; and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. It offers microarray printing technology, which allows the manufacture of DNA, protein, antibody, lipid, carbohydrate, and other types of microarrays for research and diagnostic applications, including gene expression, genotyping, protein profiling, and others. The company also provides automated microarray manufacturing instruments, including NanoPrint, SpotBot Titan, SpotBot Extreme, SpotBo Protein, and Personal microarrayers, as well as SpotLight CCD fluorescence scanners, SpotWare colorimetric scanners, InnoScan laser scanners, TrayMix hybridization stations, ArrayMix hybridization stations, centrifuges, air jets, vacuum products, and laboratory tools and bioinformatics computers. In addition, it manufactures consumables, such as glass substrates and slides, reagents, solutions, kits, and clean room supplies; and provides variation identification platform technology that allows diagnostic tests to be performed by depositing approximately 100,000 patient samples onto a single microarray. Further, the company is involved in the import, export, manufacture, and distribution of wholesale industrial chemicals. Arrayit Corporation offers its tools and services to genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies, and biotechnology companies. The company is headquartered in Sunnyvale, California.

9 Employees
Last Reported Date: 08/19/14

arrayit corp (ARYC) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: --
President, Chief Science Officer, Treasurer, ...
Total Annual Compensation: --
Founder, Executive Vice President and Directo...
Total Annual Compensation: $50.0K
Compensation as of Fiscal Year 2013.

arrayit corp (ARYC) Key Developments

Arrayit Corporation Enters into an Agreement with Array Molecular Corp

Arrayit Corporation announced that on August 19, 2014, the company entered into an agreement with Array Molecular Corp. to commercialize a DNA microarray platform for detecting pathogens in food. Under the terms of the agreement, the company will contribute a license to its patents and all intellectual property associated with this test in exchange for 24% of the outstanding shares of Array Molecular. Array Molecular will provide at least $2 million toward the commercialization effort.

Arrayit Corporation Announces Settlement of Lawsuit with Avant Diagnostics, Inc

Arrayit Corporation announced that on August 20, 2014, the Avant Diagnostics Inc. case against Arrayit Corporation was dismissed by court order and by agreement of the parties. Further on August 6, 2014 Arrayit Corporation entered into an agreement under which Arrayit maintains the exclusive right to manufacture OvaDx for Avant Diagnostics Inc. until such time as the rights are sold to a third party. The invoice for $1,550,000 from Arrayit to Avant is to be settled by the issuance of ten million (10,000,000) shares of Avant to Arrayit, which shares are ultimately to be a dividend to the shareholders of Arrayit. The agreement further stipulates a swap of ten million (10,000,000) shares between the two companies.

Arrayit Corporation, Q2 2014 Earnings Call, Aug 26, 2014

Arrayit Corporation, Q2 2014 Earnings Call, Aug 26, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARYC:US $0.16 USD +0.004

ARYC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Affymetrix Inc $8.27 USD -0.26
Agilent Technologies Inc $58.25 USD -0.15
BioMerieux €82.40 EUR +0.91
Illumina Inc $172.26 USD -5.66
Vermillion Inc $1.92 USD +0.05
View Industry Companies
 

Industry Analysis

ARYC

Industry Average

Valuation ARYC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARRAYIT CORP, please visit www.arrayit.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.